retina controversy: biosimilar to biosimilar anti-vegf switching for retinal diseases
Published 8 months ago • 479 plays • Length 15:45Download video MP4
Download video MP3
Similar videos
-
25:47
what is a retina specialist?
-
2:40
what is a retina specialist?
-
5:13
biologics, biosimilars and generics for the treatment of retinal disease
-
2:14
the anti-vegf biosimilars paradox | ravi parikh, m.d., m.p.h., asrs 2023
-
2:06
eye to eye: what is a retina?
-
3:51
alay s. banker, md: biosimilars bevacizumab, ranibizumab for retinal diseases
-
23:09
the patient’s role in maintaining retinal health | full episode
-
1:37:56
biosimilars for retinal diseases- indo-us symposium - 7 pm - 29 aug
-
1:57
eye to eye: nutrition and retinal health
-
3:41
see for a lifetime: ferne's story
-
2:10
what is the retina and how is it affected by disease?
-
28:37
patient's guide to eye injections
-
11:20
dr chaitra jayadev biosimilars future impact in retinal diseases
-
0:22
macular degeneration treatment - intravitreal injection into the eyeball
-
4:42
biosimilars vs. biologics: side effects, safety and effectiveness
-
1:02:10
introduction of biosimilars on the nhs
-
51:51
2022 vitreoretinal and macular disease update